List of Excipients in API darifenacin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing darifenacin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | HYPROMELLOSES | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | MAGNESIUM STEARATE | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | POLYETHYLENE GLYCOL 200 | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | TALC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing darifenacin
Detailed excipient profiles for darifenacin
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
darifenacin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| Cipla USA Inc | darifenacin hydrobromide | 69097-431 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
darifenacin drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
darifenacin drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
darifenacin drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
darifenacin drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
darifenacin drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
darifenacin drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
darifenacin drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
darifenacin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
darifenacin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
darifenacin drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
darifenacin drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
darifenacin drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
darifenacin drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
darifenacin drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
darifenacin drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| Jubilant Cadista Pharmaceuticals Inc | darifenacin hydrobromide | 59746-516 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
darifenacin drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
darifenacin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
darifenacin drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
darifenacin drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
darifenacin drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
darifenacin drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1500
darifenacin drug variants containing POLYETHYLENE GLYCOL 1500
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 1500
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 200
darifenacin drug variants containing POLYETHYLENE GLYCOL 200
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 200
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
darifenacin drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| POLYGEN PHARMACEUTICALS INC | darifenacin hydrobromide | 52605-067 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
darifenacin drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | darifenacin hydrobromide | 69097-431 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
darifenacin drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
darifenacin drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | darifenacin hydrobromide | 59746-516 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
darifenacin drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
darifenacin drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
darifenacin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
darifenacin drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
darifenacin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
